Key takeaways:
Neuroendocrine tumors are rare cancers that come from neuroendocrine cells that release hormones.
These tumors can occur anywhere in the body, but they’re most common in the gastrointestinal tract and lungs.
Most neuroendocrine tumors are highly treatable.
There are many types of tumors. And, let’s face it, no one wants to get the news they have one. So we’re here to help you understand the details so you can confidently approach the next steps.
Neuroendocrine tumors (NETs) are a rare type of tumor. Only about 12,000 people in the U.S. are diagnosed with NETs per year. There are many different types of NETs, and they can occur anywhere in the body. NETs equally affect men and women. Most NETs grow slowly and are very treatable.
In this article, we discuss the causes, symptoms, diagnosis, and treatment of NETs.
To understand NETs, you first need to understand a bit about the cells they come from — neuroendocrine cells. “Neuro” means nerves, and “endocrine” means hormones. So neuroendocrine cells are special cells that respond to signals from nerves by releasing hormones.
Neuroendocrine cells are found all over the body. Locations include the:
Stomach and bowels (gastrointestinal tract)
Lungs
Pancreas
Pituitary gland (brain)
Adrenal glands
Thyroid and parathyroid glands in the neck
Kidneys and bladder
Genital organs (like the ovaries and prostate)
NETs happen when a neuroendocrine cell becomes cancerous. Cancerous cells result from changes (mutations) in DNA that cause them to reproduce rapidly. The more copies a cancerous cell makes of itself, the bigger the tumor.
Some NETs are hereditary — meaning they’re related to genetic conditions that cause tumors. Multiple endocrine neoplasia type 1 is an example. But most NETs are sporadic — meaning they happen out of nowhere.
NETs differ from other tumors in two ways:
Location: Neuroendocrine cells are all over the body, and so are NETs. Other tumors start in specific organs. For example, breast cancer starts in the breast. But NETs can start anywhere. The most common locations include the gastrointestinal tract (65%) and lungs (25%).
Release of hormones: Some NETs are “functional” — meaning they release more hormones than they should. Too much of any hormone leads to specific symptoms that other tumors don’t have.
Since there are so many different kinds of NETs, symptoms vary. Every person has their own unique combination of symptoms, and some people may not have symptoms at all.
Symptoms fall into three main categories.
Weight loss
Lack of appetite
Fatigue
Pain
Lump or mass-like growth
Shortness of breath, cough, or coughing up blood (tumors in the lung)
Diarrhea, constipation, or bloody stools (tumors in the gastrointestinal tract)
Abdominal pain, stomach ulcers, and diarrhea — when NETs release too much stomach acid
Low blood sugar — when NETs release too much insulin
Flushing of the face, wheezing, rapid heartbeat, and diarrhea (carcinoid syndrome)
NETs can be harder to diagnose than other types of tumors since there are so many different kinds of them. NETs that release hormones tend to be diagnosed earlier because the symptoms of too much hormone prompt people to seek medical care sooner.
To diagnose a NET, your healthcare provider might order any of these tests:
CT or MRI imaging
Endoscopy, which involves inserting a camera into the stomach or rectum to examine the inside of the stomach or bowels
Special imaging, which involves injecting a radioactive substance into a vein to locate tumor cells (like octreotide scans)
Blood or urine tests to check hormone levels (tumor markers)
A primary care provider or emergency room doctor may diagnose NETs. If testing confirms a cancer diagnosis, an oncologist (cancer specialist) will take the lead when it comes to treatment.
Most NETs are very treatable. Treatment depends on a couple of different factors:
Type of neuroendocrine cell causing the NET
Location of the NET
Any metastasis (spread) of the NET and how quickly the NET is growing or spreading
Surgery is often the treatment for NETs that haven’t spread yet. Medications are preferred for the 12% to 22% of NETs that have metastasized at the time of diagnosis. Recommendations for medication usually depend on the type of NET. Researchers are working hard to develop new treatments.
A solid support system and tools to help cope with a cancer diagnosis and treatment are important, too.
NETs are a rare and varied type of cancer that cause a range of symptoms. They’re different from other tumor types, but cancer of any kind is scary. The good news is most NETs are treatable, and new therapies are coming down the pipeline every year. Together with your healthcare provider and a support system, you’ll find a way through this.
American Society of Clinical Oncology. (2019). Multiple endocrine neoplasia type 1. Cancer.net.
American Society of Clinical Oncology. (2021). Neuroendocrine tumors: Latest research. Cancer.net.
American Society of Clinical Oncology. (2021). Neuroendocrine tumors: Symptoms and signs. Cancer.net.
American Society of Clinical Oncology. (2022). Neuroendocrine tumors: Statistics. Cancer.net.
Gut, P., et al. (2015). Familial syndromes associated with neuroendocrine tumors. Contemporary Oncology.
Hibbs, S. (2019). What are tumor marker tests for cancer? 8 things you need to know. American Society of Clinical Oncology.
National Cancer Institute. (n.d.). Octreotide scan.
Oronsky, B., et al. (2017). Nothing but NET: A review of neuroendocrine tumors and carcinomas. Neoplasia.
Pandit, S., et al. (2022). Carcinoid syndrome. StatPearls.
Taal, B. G., et al. (2004). Epidemiology of neuroendocrine tumors. Neuroendocrinology.